3,4-methylenedioxyamphetamine has been researched along with Acute-Phase Reaction in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Acute-Phase Reaction: An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouzoulis-Mayfrank, E | 1 |
| Thelen, B | 1 |
| Habermeyer, E | 1 |
| Kunert, HJ | 1 |
| Kovar, KA | 1 |
| Lindenblatt, H | 1 |
| Hermle, L | 1 |
| Spitzer, M | 1 |
| Sass, H | 1 |
1 trial available for 3,4-methylenedioxyamphetamine and Acute-Phase Reaction
| Article | Year |
|---|---|
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.
Topics: 3,4-Methylenedioxyamphetamine; Acute-Phase Reaction; Adult; Aged; Autonomic Agents; Central Nervous | 1999 |